CWA Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Buy |
|
|||||
|
2025
Q1 | $7.07M | Buy |
|
|||||
|
2024
Q4 | $6.29M | Buy |
|
|||||
|
2024
Q3 | $4.51M | Buy |
|
|||||
|
2024
Q1 | $6.37M | Buy |
|
|||||
|
2023
Q4 | $1.31M | Buy |
|
|||||
|
2023
Q3 | $471K | Buy |
|
|||||
|
2023
Q2 | $500K | Buy |
|
|||||
|
2023
Q1 | $439K | Sell |
|
|||||
|
2022
Q4 | $706K | Sell |
|
|||||
|
2022
Q3 | $715K | Buy |
|
|||||
|
2022
Q2 | $763K | Sell |
|
|||||
|
2022
Q1 | $725K | Buy |
|
|||||
|
2021
Q4 | $389K | Sell |
|
|||||
|
2021
Q3 | $412K | Buy |
|
|||||
|
2021
Q2 | $423K | Sell |
|
|||||
|
2021
Q1 | $443K | Buy |
|
|||||
|
2020
Q4 | $435K | Sell |
|
|||||
|
2020
Q3 | $450K | Sell |
|
|||||
|
2020
Q2 | $490K | Sell |
|
|||||
|
2020
Q1 | $519K | Sell |
|
|||||
|
2019
Q4 | $685K | Buy |
|